Subsalve USA and Nanotronics Health donate medical devices and provide on-site training across Rhode Island healthcare system in joint humanitarian effort
QUONSET, R.I. & NEW YORK–(BUSINESS WIRE)–Quonset Rhode Island based, Subsalve USA and Brooklyn, New York based, Nanotronics Health, have teamed up in their first domestic partnership, to provide humanitarian relief to clinicians in Rhode Island as they face a tremendous COVID-19 surge, and potential shortage of hospital beds and staff. Both Nanotronics Health and Subsalve USA received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for their respective devices to treat COVID-19. Paired together, the non-invasive respiratory support package significantly minimizes aerosolized spread in hospitals and aims to free-up critical ICU resources for those with more severe symptoms.
The Subsalve-Nanotronics partnership initially formed through an international aid distribution effort.
“The system is fantastic and already saved and is continuing to save lives in Bolivia,” said primary care physician Dr. Cesar Vargas on the front lines of COVID-19 treatment in Bolivia. “Our physicians are more familiar and eager to use the device and share the benefits with other hospitals.”
Subsalve USA’s Subsalve Oxygen Treatment Hood is a patient interface intended for helmet-based Non-Invasive Positive Pressure Ventilation, according to clinician-established protocols to treat Acute Respiratory Distress Symptoms resulting from COVID-19. The device is for use with adult patients only in Intensive Care Unit settings and is a mode of non-invasive ventilation (NIV) that provides increased patient airway pressure, delivery of therapeutic oxygen.
Nanotronics Health’s nHale™ is a bi-level positive air pressure (BiPAP) device that supports the respiratory therapy of spontaneously breathing COVID-19 patients. It is approved under EUA for patients suffering from COVID-19 disease in private homes, traditional healthcare facilities (e.g. hospitals, assisted living facilities, nursing homes), as well as spaces converted for the care of large numbers of COVID-19 patients (e.g. convention centers, university dormitories, hotels, etc.)
Michael Lombardi, founder and president of Lombardi Undersea LLC and partner to Subsalve’s NIV interests said, “After months of evaluating multiple BiPAP/CPAP devices for suitability in helmet ventilation, we believe the nHale™ affords the most suitable turn-key solution for ease of use, simple helmet interfacing, and eliminates considerable guesswork for the clinicians.”
Nanotronics and Subsalve are prepared to scale this solution for hospitals worldwide. A technical demonstration was hosted at Subsalve USA earlier this week to demonstrate treating multiple patients simultaneously to help emergency management decision makers visualize mass-triage capabilities for respiratory distress.
This current effort was made possible through cooperative recognition that urgent action was needed in the State of Rhode Island, who as of this week, had the highest COVID-19 infection rate worldwide. The humanitarian action was supported by anonymous charitable donations and private individuals contributing to Ocean Opportunity Inc., a RI based 501(c)3 not for profit organization that is sponsoring the initiative. Donations to this initiative are making helmet ventilation available in resource limited countries. Donate today.
or visit www.oxygentreatmenthoods.com
#beatcovid19 #oxygentreatmenthoods #preventthevent #helmetventilation